Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 146.00
-3.60 (-2.41%)
Aug 15, 2025, 5:29 PM CET
Devyser Diagnostics AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Revenue | 235.1 | 216.9 | 169.3 | 126.6 | 93.48 | 65.69 | Upgrade
|
| Revenue Growth (YoY) | 19.89% | 28.12% | 33.73% | 35.43% | 42.31% | 2.15% | Upgrade
|
| Cost of Revenue | 43.3 | 44.2 | 24.5 | 23.2 | 21.57 | 18.67 | Upgrade
|
| Gross Profit | 191.8 | 172.7 | 144.8 | 103.4 | 71.91 | 47.02 | Upgrade
|
| Selling, General & Admin | 195.7 | 193.1 | 163.5 | 132.1 | 75.65 | 41.9 | Upgrade
|
| Research & Development | 30.5 | 43.1 | 37.8 | 26.3 | 18.07 | 16.68 | Upgrade
|
| Other Operating Expenses | 0.9 | -0.9 | -0.3 | -0.2 | -0.12 | -2.38 | Upgrade
|
| Operating Expenses | 227.1 | 235.3 | 201 | 158.2 | 93.6 | 56.21 | Upgrade
|
| Operating Income | -35.3 | -62.6 | -56.2 | -54.8 | -21.69 | -9.19 | Upgrade
|
| Interest Expense | -12.1 | -3.5 | -0.8 | -0.5 | -0.94 | -0.93 | Upgrade
|
| Interest & Investment Income | - | 4.2 | 5 | 0.3 | 0.01 | 0 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | 0.37 | -1.04 | Upgrade
|
| Currency Exchange Gain (Loss) | 4.8 | 4.8 | -2.3 | 1.2 | 0.06 | -0.74 | Upgrade
|
| Other Non Operating Income (Expenses) | - | -0.1 | - | - | 0.22 | 0 | Upgrade
|
| EBT Excluding Unusual Items | -42.6 | -57.2 | -54.3 | -53.8 | -21.97 | -11.9 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 1.6 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.4 | -0.4 | -0.4 | 0.1 | 0.07 | - | Upgrade
|
| Asset Writedown | - | - | 0.3 | -0.7 | -0 | - | Upgrade
|
| Pretax Income | -43 | -57.6 | -54.4 | -52.8 | -21.91 | -11.9 | Upgrade
|
| Income Tax Expense | 2.7 | 3.9 | -0.8 | -6.8 | -1.18 | -0.99 | Upgrade
|
| Net Income | -45.7 | -61.5 | -53.6 | -46 | -20.73 | -10.91 | Upgrade
|
| Net Income to Common | -45.7 | -61.5 | -53.6 | -46 | -20.73 | -10.91 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 16 | 16 | 16 | 11 | 9 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 16 | 16 | 16 | 11 | 9 | Upgrade
|
| Shares Change (YoY) | 1.65% | 1.34% | 1.63% | 41.78% | 28.98% | -4.34% | Upgrade
|
| EPS (Basic) | -2.76 | -3.75 | -3.31 | -2.89 | -1.85 | -1.25 | Upgrade
|
| EPS (Diluted) | -2.76 | -3.75 | -3.31 | -2.89 | -1.85 | -1.25 | Upgrade
|
| Free Cash Flow | -22.7 | -72.6 | -81.2 | -48.4 | -18.68 | 0.55 | Upgrade
|
| Free Cash Flow Per Share | -1.37 | -4.43 | -5.02 | -3.04 | -1.66 | 0.06 | Upgrade
|
| Gross Margin | 81.58% | 79.62% | 85.53% | 81.67% | 76.93% | 71.58% | Upgrade
|
| Operating Margin | -15.02% | -28.86% | -33.20% | -43.29% | -23.20% | -13.99% | Upgrade
|
| Profit Margin | -19.44% | -28.35% | -31.66% | -36.34% | -22.17% | -16.61% | Upgrade
|
| Free Cash Flow Margin | -9.65% | -33.47% | -47.96% | -38.23% | -19.98% | 0.84% | Upgrade
|
| EBITDA | -29.2 | -56.1 | -52.5 | -52.6 | -20.99 | -8.63 | Upgrade
|
| EBITDA Margin | -12.42% | -25.86% | -31.01% | -41.55% | -22.46% | -13.13% | Upgrade
|
| D&A For EBITDA | 6.1 | 6.5 | 3.7 | 2.2 | 0.69 | 0.57 | Upgrade
|
| EBIT | -35.3 | -62.6 | -56.2 | -54.8 | -21.69 | -9.19 | Upgrade
|
| EBIT Margin | -15.02% | -28.86% | -33.20% | -43.29% | -23.20% | -13.99% | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.